← Leaderboards
Yael P Mosse
Children'S Hosp Of Philadelphia
$12,182,604
Attributed
$12,182,604
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,182,604 · 5
By mechanism
R01$5,635,629 · 1
U01$3,549,742 · 1
P01$2,315,153 · 2
K08$682,080 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Kristopher R Bosse$2,270,831
- Edward F Attiyeh$696,600
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorNeuroblastomaMalignant Childhood NeoplasmChildPre-ClinicalOncogenicClinical TrialsOncogenesMutationDiagnosisClinicBaseHigh RiskRelapseUnited States National Institutes Of HealthMissionEvidence BaseDesignTumorigenesisResponseChemotherapyMolecularImproved Outcome
Grant awards (32)
NCI Pediatric In Vivo Testing Program: Neuroblastoma$712,799
U01 · FY2025 · CA · contact PI
Targeting evolving therapy resistance$407,872
P01 · FY2025 · CA · contact PI
NCI Pediatric In Vivo Testing Program: Neuroblastoma$712,799
U01 · FY2024 · CA · contact PI
Targeting evolving therapy resistance$400,151
P01 · FY2024 · CA · contact PI
NCI Pediatric In Vivo Testing Program: Neuroblastoma$712,800
U01 · FY2023 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$418,000
R01 · FY2023 · CA · contact PI
NCI Pediatric In Vivo Testing Program: Neuroblastoma$698,544
U01 · FY2022 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$409,640
R01 · FY2022 · CA · contact PI
NCI Pediatric In Vivo Testing Program: Neuroblastoma$712,800
U01 · FY2021 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$401,461
R01 · FY2021 · CA · contact PI
Proj 1 - Targeting Evolving Therapy Resistance$320,207
P01 · FY2021 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$401,600
R01 · FY2020 · CA · contact PI
Proj 1 - Targeting Evolving Therapy Resistance$302,817
P01 · FY2020 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$437,836
R01 · FY2019 · CA · contact PI
Targeting Evolving Therapy Resistance$269,130
P01 · FY2019 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$374,304
R01 · FY2018 · CA · contact PI
Targeting Evolving Therapy Resistance$286,843
P01 · FY2018 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$374,324
R01 · FY2017 · CA · contact PI
Targeting Evolving Therapy Resistance$328,133
P01 · FY2017 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$374,344
R01 · FY2016 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$378,479
R01 · FY2015 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$404,266
R01 · FY2014 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$311,233
R01 · FY2013 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$331,098
R01 · FY2012 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$331,098
R01 · FY2011 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$343,973
R01 · FY2010 · CA · contact PI
Targeting Oncogenic ALK Signaling in Neuroblastoma$343,973
R01 · FY2009 · CA · contact PI
GENOMICS OF HUMAN NEUROBLASTOMA$124,800
K08 · FY2009 · CA · contact PI
GENOMICS OF HUMAN NEUROBLASTOMA$139,320
K08 · FY2008 · CA · contact PI
GENOMICS OF HUMAN NEUROBLASTOMA$139,320
K08 · FY2007 · CA · contact PI
GENOMICS OF HUMAN NEUROBLASTOMA$139,320
K08 · FY2006 · CA · contact PI
GENOMICS OF HUMAN NEUROBLASTOMA$139,320
K08 · FY2005 · CA